Why the study?
Does left ventricular global function index (LVGFI) measured by CMR predict major adverse cardiac events in patients after STEMI?
Does left ventricular global function index (LVGFI) measured by CMR predict major adverse cardiac events in patients after STEMI?
LVGFI assessed by CMR is a strong predictor of MACE after STEMI, but does not offer incremental prognostic value over standard LVEF.
No takes yet. Share an insight, caveat, or question.
LVGFI by CMR may aid post-STEMI risk stratification; leaves open incremental value over LVEF in prospective cohorts.
Reinstadler et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: